[EN] COMPOUNDS TARGETING Y220C MUTANT OF P53<br/>[FR] COMPOSÉS CIBLANT LE MUTANT Y220C DE P53
申请人:JACOBIO PHARMACEUTICALS CO LTD
公开号:WO2022213975A1
公开(公告)日:2022-10-13
Provided are compounds of formula (I) which can bind to p53 mutant and restore its ability to bind DNA and activate downstream effects involved in tumor suppression. Also provided are the synthesis processes and use of the compounds.
提供的是式(I)的化合物,它们可以结合p53突变体,并恢复其结合DNA和激活涉及肿瘤抑制的下游效应的能力。还提供了化合物的合成过程和用途。